Home | Medical-Newswire.Com:
(Medical-NewsWire.com, September 13, 2017 ) The Asia Pacific Contraceptives Market was worth $ 4.73 billion in 2016 and estimated to reach $ 6.62 billion by the end of 2021 with a growing potential of 6.95 %. Regionally, Asia Pacific was highly influencing the industry in terms of demographics and lack of awareness within the large population. Favourable government initiatives pertaining to sex education of individuals is one of the major factor expected to boost the contraceptives market growth over the forecast period.
Vaginal implants, Male and female condoms, subdermal implants, sponges, IUDs and diaphragms are important devices that accounts for the largest share in the market in terms of revenue. This is attributed to growing awareness about STD (Sexually transmitted disease) and the efficiency of condoms to inhibit the infections, including HIV.
Full report at: http://www.marketdataforecast.com/market-reports/asia-pacific-contraceptives-market-1231/
The Asia Ė pacific market is driven by growing development of effective female contraceptive devices and drugs, advancement in technologies, increasing initiatives by the government and NGO to promote contraceptives. Restraints the growth of the market are the side effects associated with the use of contraceptive devices and drugs, rising prevalence of infertility.
Based on drug type the market is segmented into Contraceptive pills, Topical contraceptives, Contraceptive injectable, Others (contraceptive gels, jellies and creams).
Based on medical devices the market is segmented into Male contraceptive devices (Condoms), Female contraceptive devices. Female contraceptive devices are further classified into female condoms, intrauterine devices (Hormonal IUDís, Copper IUDís), contraceptive sponges, contraceptive diaphragms, contraceptive patches, subdermal contraceptive implants and non-surgical permanent contraceptive devices.
Based on end users the market is segmented into Hospitals, Home care, Clinics and Ambulatory Surgical Centres.The Asia - Pacific market is analyzed under various regions namely Japan, China, India, and Australia.
Request sample: http://www.marketdataforecast.com/market-reports/asia-pacific-contraceptives-market-1231/request-sample
Major players operating in Asia - Pacific contraceptives market are Bayer HealthCare AG, Teva Pharmaceutical Industries Limited, Medisafe Distribution Inc, Pace Pharmaceuticals Inc., Medicines360, Church & Dwight, Co., Inc., Actavis, Inc., CooperSurgical, Inc., Merck & Co., Inc., Reckitt Benckiser plc, Mayer Laboratories, Inc., and Pfizer, Inc.
About Market Data Forecast:
The publisher of this report is Market Data Forecast whose forte lies in Market research and Business Intelligence. Handling both individual and corporate clients across multiple business domains they offer syndicated/customized research to suit the clientís research objective. Their research reports section offers a wide variety of market studies ranging from all-encompassing comprehensive market studies to product specific niche markets covering North America among other regions of the global market as well. For more info kindly visit, www.marketdataforecast.com
Sales Manager (International Business Development)
Market Data Forecast
Direct Line: +1-888-702-9626
Mobile: +91 998 555 0206
Visit MarketDataForecast Blog @ http://www.marketdataforecast.com/blog/
View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases
Market Data Forecast